Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies

European Journal of Endocrinology

Volumn 169, Issue 4, 2013, Pages 383-390

  Lips, Mirjam A ^a   De Groot, Gerrit H ^b   De Kam, Marieke ^c   Berends, Frits J ^d   Wiezer, Renee ^e   Van Wagensveld, Bart A ^e,f   Swank, Dingeman J ^g   Luijten, Arijan ^h   Pijl, Hanno ^a   Burggraaf, Jacobus ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RED CROSS HOSPITAL   (Netherlands)

^c CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

^f ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^g Nederlandse Obesitaskliniek West   (Netherlands)

^h MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LEPTIN; METFORMIN;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; ADULT; ANXIETY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CALORIC INTAKE; CALORIC RESTRICTION; CAUCASIAN; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC OBESITY; DIGESTIVE SURGICAL DEVICE; FEMALE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART RATE VARIABILITY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; INTERMETHOD COMPARISON; LAPBAND; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN SECRETION; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; SYMPATHETIC FUNCTION; TREATMENT DURATION; VERY LOW CALORIE DIET; WEIGHT REDUCTION;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; FEMALE; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; MIDDLE AGED; OBESITY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME; VAGUS NERVE; WEIGHT LOSS;

EID: 84884886450     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0506     Document Type: Article

References (37)

1. Matthaei S, Stumvoll M, Kellerer M & Haring HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocrine Reviews 2000 21 585-618. (doi:10.1210/er.21.6.585) (Pubitemid 32113286)
2. Muoio DM & Newgard CB. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and b-cell failure in type 2 diabetes. Nature Reviews. Molecular Cell Biology 2008 9 193-205. (doi:10.1038/nrm2327) (Pubitemid 351301824)
3. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ & Baskin DG. Central nervous system control of food intake. Nature 2000 404 661-671. (Pubitemid 30205071)
4. Emdin M, Gastaldelli A, Muscelli E, Macerata A, Natali A, Camastra S & Ferrannini E. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation 2001 103 513-519. (doi:10.1161/01.CIR. 103.4.513) (Pubitemid 32116235)
5. Muscelli E, Emdin M, Natali A, Pratali L, Camastra S, Gastaldelli A, Baldi S, Carpeggiani C & Ferrannini E. Autonomic and hemodynamic responses to insulin in lean and obese humans. Journal of Clinical Endocrinology and Metabolism 1998 83 2084-2090. (doi:10.1210/jc.83.6.2084) (Pubitemid 28496341)
6. Cuspidi C, Meani S, Valerio C, Sala C, Fusi V, Zanchetti A & Mancia G. Age and target organ damage in essential hypertension: role of the metabolic syndrome. American Journal of Hypertension 2007 20 296-303. (doi:10.1016/j. amjhyper.2006.09.010) (Pubitemid 46283362)
7. Festa A, D'Agostino R Jr, Hales CN, Mykkanen L & Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care 2000 23 624-628. (doi:10.2337/diacare.23.5.624) (Pubitemid 30321541)
8. Lehtinen JM, Uusitupa M, Siitonen O & Pyorala K. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989 38 1307-1313. (doi:10.2337/diabetes. 38.10.1307) (Pubitemid 19247428)
9. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM & Levy D. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). American Journal of Cardiology 2000 86 309-312. (doi:10.1016/S0002-9149(00)00920-6) (Pubitemid 30462227)
10. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J & Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. Journal of Hypertension 2007 25 909-920. (doi:10.1097/HJH.0b013e328048d004) (Pubitemid 46573105)
11. Straznicky NE, Eikelis N, Lambert EA & Esler MD. Mediators of sympathetic activation in metabolic syndrome obesity. Current Hypertension Reports 2008 10 440-447. (doi:10.1007/s11906-008-0083-1)
12. Bergholm R, Westerbacka J, Vehkavaara S, Seppala-Lindroos A, Goto T & Yki-Jarvinen H. Insulin sensitivity regulates autonomic control of heart rate variation independent of body weight in normal subjects. Journal of Clinical Endocrinology and Metabolism 2001 86 1403-1409. (doi:10.1210/jc.86.3.1403) (Pubitemid 32323035)
13. Watanabe T, Nomura M, Nakayasu K, Kawano T, Ito S & Nakaya Y. Relationships between thermic effect of food, insulin resistance and autonomic nervous activity. Journal of Medical Investigation 2006 53 153-158. (doi:10.2152/jmi.53.153)
14. Huggett RJ, Scott EM, Gilbey SG, Bannister J, Mackintosh AF & Mary DA. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 2005 48 172-179. (doi:10.1007/s00125-004-1601-6) (Pubitemid 40174670)
15. Straznicky NE, Lambert GW & Lambert EA. Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss. Current Opinion in Lipidology 2010 21 21-30. (doi:10.1097/MOL. 0b013e3283329c62)
16. Tentolouris N, Liatis S & Katsilambros N. Sympathetic system activity in obesity and metabolic syndrome. Annals of the New York Academy of Sciences 2006 1083 129-152. (doi:10.1196/annals. 1367.010) (Pubitemid 44955470)
17. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996 93 1043-1065. (doi:10.1161/01.CIR.93.5.1043)
18. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, Greve JW, Horber F, Mathus-Vliegen E, Scopinaro N et al. Interdisciplinary European guidelines on surgery of severe obesity. International Journal of Obesity 2007 31 569-577. (Pubitemid 46482359)
19. Korner J, Bessler M, Inabnet W, Taveras C & Holst JJ. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surgery for Obesity and Related Diseases 2007 3 597-601. (doi:10.1016/j.soard. 2007.08.004) (Pubitemid 350091417)
20. Levy JC, Matthews DR & Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 2191-2192. (doi:10.2337/diacare.21. 12.2191) (Pubitemid 28549174)
21. Nault I, Nadreau E, Paquet C, Brassard P, Marceau P, Marceau S, Biron S, Hould F, Lebel S, Richard D et al. Impact of bariatric surgery-induced weight loss on heart rate variability. Metabolism 2007 56 1425-1430. (doi:10.1016/j.metabol.2007.06.006) (Pubitemid 47404607)
22. Perugini RA, Li Y, Rosenthal L, Gallagher-Dorval K, Kelly JJ & Czerniach DR. Reduced heart rate variability correlates with insulin resistance but not with measures of obesity in population undergoing laparoscopic Roux-en-Y gastric bypass. Surgery for Obesity and Related Diseases 2010 6 237-241. (doi:10.1016/j. soard.2009.09.012)
23. Anderson EA, Hoffman RP, Balon TW, Sinkey CA & Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. Journal of Clinical Investigation 1991 87 2246-2252. (doi:10.1172/JCI115260)
24. Bellavere F, Cacciatori V, Moghetti P, Gemma ML, Dellera A, Tosi F, Negri C, Thomaseth K & Muggeo M. Acute effect of insulin on autonomic regulation of the cardiovascular system: a study by heart rate spectral analysis. Diabetic Medicine 1996 13 709-714. (doi:10.1002/(SICI)1096-9136(199608)13:8!709:: AIDDIA158O3.0. CO;2-8) (Pubitemid 26252948)
25. Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Lansimies EA, Uusitupa MI & Laakso M. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 1999 48 1295-1299. (doi:10.2337/diabetes.48.6.1295) (Pubitemid 29241029)
26. Seals DR & Bell C. Chronic sympathetic activation: consequence and cause of age-associated obesity? Diabetes 2004 53 276-284. (doi:10.2337/ diabetes.53.2.276) (Pubitemid 38174541)
27. Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI & Mark AL. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002 51 439-442. (doi:10.2337/diabetes.51.2.439) (Pubitemid 34764800)
28. Rahmouni K, Haynes WG, Morgan DA & Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002 39 486-490. (doi:10.1161/hy0202.102836) (Pubitemid 34165170)
29. Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Current Hypertension Reviews 2010 6 104-209. (doi:10.2174/157340210791170994)
30. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992 15 1835-1843. (doi:10.2337/diacare.15.12.1835)
31. Greene DA, Lattimer SA & Sima AA. Are disturbances of sorbitol, phosphoinositide, and NaC-KC-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 1988 37 688-693. (doi:10.2337/diabetes.37.6.688) (Pubitemid 19043173)
32. Thorell A, Nygren J & Ljungqvist O. Insulin resistance: a marker of surgical stress. Current Opinion in Clinical Nutrition and Metabolic Care 1999 2 69-78. (doi:10.1097/00075197-199901000-00012) (Pubitemid 129628628)
33. Jazet IM, Pijl H, Frolich M, Romijn JA & Meinders AE. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin. Metabolism 2005 54 705-712. (doi:10.1016/j.metabol.2004.12. 015) (Pubitemid 40725317)
34. Ireland N, Meagher J, Sleigh JW & Henderson JD. Heart rate variability in patients recovering from general anaesthesia. British Journal of Anaesthesia 1996 76 657-662. (doi:10.1093/bja/76.5.657) (Pubitemid 26129539)
35. Lips MA, de Groot GH, van Klinken J, Aarts E, Berends FJ, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F et al. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients. Clinical Endocrinology 2013.
36. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. Journal of Clinical Investigation 2002 110 43-52. (Pubitemid 34743464)
37. Bilchick KC & Berger RD. Heart rate variability. Journal of Cardiovascular Electrophysiology 2006 17 691-694. (doi:10.1111/j.1540-8167.2006. 00501.x)